Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Telmisartan Plus Hydrochlorothiazide in Subjects With Mild-to-moderate Hypertension Who Failed to Respond to Telmisartan Monotherapy [Phase 3]
Phase 3 trial assessing the combination of telmisartan and hydrochlorothiazide in patients with mild-to-moderate hypertension who did not re…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: MICARDIS® and Valsartan in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring [Phase 3]
Phase 3 clinical trial update assessing MICARDIS (telmisartan) and valsartan in patients with mild-to-moderate hypertension using ambulatory…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Telmisartan Compared With Enalapril in Elderly Patients With Blood Hypertension [Phase 4]
Phase 4 trial comparing telmisartan with enalapril in elderly patients with hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Natriuretic Effect of Telmisartan Versus Placebo in Patients With Mild-to-Moderate Hypertension [Phase 3]
A Phase 3 trial comparing telmisartan to placebo in patients with mild-to-moderate hypertension assessing natriuretic effects; the study has…
-
CLINICAL_TRIALS trial_result · 2014-07-08Clinical Trial Update: Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate Hypertension [Phase 3]
This update indicates that the Phase 3 trial evaluating telmisartan with or without hydrochlorothiazide in patients with mild-to-moderate hy…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-07-07FDA Approved: TELMISARTAN — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approves Glenmark's original submission for Telmisartan, a generic angiotensin II receptor blocker indicated for hypertension.
-
FDA approval · 2014-07-07FDA Approved: TELMISARTAN — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved Mylan Pharmaceuticals' original ANDA for a generic telmisartan product. The approval makes a generic version of telmisartan ava…
-
FDA approval · 2014-07-07FDA Approved: TELMISARTAN — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original application for a generic telmisartan product.
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Phase 4 Study to Assess the Effect of Bisoprolol on Glycemic Level in Type II Diabetic Subjects With Suboptimal Blood Pressure Control [Phase 4]
Phase 4 clinical trial evaluated the effect of the beta-blocker bisoprolol on glycemic levels in adults with type 2 diabetes and suboptimal …
-
CLINICAL_TRIALS withdrawal · 2014-07-04Clinical Trial Update: Effects of Intralipid Versus Olive Oil Infusions on Endothelial Function, Immune Function, Inflammatory Markers [Phase 2, Phase 3]
Emory University-sponsored Phase 2/3 trial evaluating intralipid versus olive oil lipid infusions, intended to assess endothelial function, …
-
FDA label_change · 2014-07-03FDA Approved: BENICAR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Benicar (olmesartan medoxomil) submitted by Cosette Pharmaceuticals, Inc.
-
FDA approval · 2014-07-02FDA Approved: AZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for AZOR (amlodipine besylate and olmesartan medoxomil) from Cosette Pharmaceuticals, Inc. This …
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: Efficacy and Safety of Telmisartan in Hypertensive Patients With Mild/Moderate or Severe Renal Impairment or Requiring Hemodialysis [Phase 4]
A Phase 4 trial update evaluating the efficacy and safety of telmisartan in hypertensive patients with varying renal impairment, including t…
-
CLINICAL_TRIALS trial_result · 2014-06-30Clinical Trial Update: Effect of the Direct Renin Inhibitor Aliskiren on Endothelial Function and Arterial Stiffness in Diabetic Subjects [Phase 4]
A Phase 4 trial evaluating the direct renin inhibitor aliskiren on endothelial function and arterial stiffness in diabetic subjects was term…
-
FDA approval · 2014-06-27FDA Approved: BENICAR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA granted a supplemental approval for Benicar (olmesartan medoxomil) submitted by Cosette Pharmaceuticals, Inc.
-
FDA approval · 2014-06-27FDA Approved: TRIBENZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for Tribenzor (olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide) submitted by Cosett…
-
FDA approval · 2014-06-27FDA Approved: BENICAR HCT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
FDA approved a supplemental application for BENICAR HCT (olmesartan medoxomil-hydrochlorothiazide) from Cosette Pharmaceuticals, Inc.
-
FDA approval · 2014-06-26FDA Approved: VALSARTAN — Original Application (Ohm Laboratories Inc.)
FDA approved Ohm Laboratories Inc.'s valsartan under an Original Abbreviated New Drug Application (ANDA), establishing a generic version of …
-
CLINICAL_TRIALS trial_result · 2014-06-26Clinical Trial Update: A Randomized Controlled Trial for Hypertension Control by Integrating Cloud BP System and CPOE [NA]
A completed randomized controlled trial evaluating hypertension control using an integrated Cloud BP system with Computerized Physician Orde…
-
CLINICAL_TRIALS research · 2014-06-25Clinical Trial Update: Cardiovascular Risk Factors And Intensive Dietary Counselling [NA]
An ongoing clinical trial sponsored by the Andalusian Regional Ministry of Health investigates whether intensive dietary counseling can infl…
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Telmisartan With or Without Hydrochlorothiazide (HCTZ) Compared With Losartan With or Without HCTZ in Mild to Moderate Hypertensive Patients [Phase 4]
A Phase 4 trial comparing telmisartan with or without hydrochlorothiazide to losartan with or without hydrochlorothiazide in adults with mil…
-
CLINICAL_TRIALS trial_result · 2014-06-24Clinical Trial Update: Indapamide Versus Hydrochlorothiazide in Elderly Hypertensive Patients With Renal Insufficiency [Phase 4]
Phase 4 clinical trial comparing indapamide to hydrochlorothiazide in elderly patients with hypertension and renal insufficiency.
-
CLINICAL_TRIALS trial_result · 2014-06-23Clinical Trial Update: High Dose BAYA1040_Nifedipine: a Long Term Combination Study [Phase 3]
A Phase 3 long-term study evaluating a high-dose BAYA1040 and Nifedipine combination for hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2014-06-23Clinical Trial Update: Nebivolol Versus Metoprolol: Sodium Sensitivity [Phase 4]
Phase 4 trial comparing nebivolol to metoprolol in hypertension with regard to sodium sensitivity; results have been posted.
-
FDA approval · 2014-06-20FDA Approved: TRIBENZOR — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for TRIBENZOR, a fixed-dose combination of olmesartan medoxomil, amlodipine besylate, and hydroc…